Cathy Burgess is quoted on the potential impact of the U.S. Food and Drug Administration’s plan to tailor an emergency use authorization to a COVID-19 vaccine.
In the News
October 28, 2020
The Pink Sheet | COVID-19 Vaccines: FDA’s Broad Authority to Craft Narrow EUAs May Push Agency Out of Its Comfort Zone
Media Contact